CAN
IONS icon

Cetera Advisor Networks’s Ionis Pharmaceuticals IONS Stock Holding History

Cetera Advisor Networks’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,081
Closed -$206K – 2867
2023
Q4 		$206K Sell
4,081
-357
-8% -$17.1K ﹤0.01% 2519
2023
Q3 		$201K Sell
4,438
-737
-14% -$30.4K ﹤0.01% 2436
2023
Q2 		$212K Buy
+5,175
New +$199K ﹤0.01% 2318
2023
Q1 		– Sell
-5,672
Closed -$214K – 2640
2022
Q4 		$214K Buy
+5,672
New +$239K ﹤0.01% 2221
2022
Q3 		– Sell
-17,276
Closed -$640K – 2130
2022
Q2 		$640K Buy
17,276
+1,295
+8% +$48.8K 0.01% 1115
2022
Q1 		$592K Buy
15,981
+3,156
+25% +$103K 0.01% 1194
2021
Q4 		$390K Buy
12,825
+273
+2% +$8.59K ﹤0.01% 1436
2021
Q3 		$421K Buy
12,552
+4,335
+53% +$163K 0.01% 1309
2021
Q2 		$328K Buy
+8,217
New +$322K ﹤0.01% 1454
2020
Q3 		– Sell
-288
Closed -$17K – 2097
2020
Q2 		$17K Buy
+288
New +$16K ﹤0.01% 2483
2019
Q2 		– Sell
-4,575
Closed -$366K – 1213
2019
Q1 		$366K Buy
+4,575
New +$295K 0.01% 790

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cetera Advisor Networks's IONS Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Ionis Pharmaceuticals (IONS) in Q1 2024, closing a stake of 4,081 shares — an estimated $206K sold.

Cetera Advisor Networks first reported a position in IONS in Q1 2019 and held it in 11 quarters. The position peaked at $640K in Q2 2022. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Ionis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 4,081 Ionis Pharmaceuticals shares in Q1 2024, an estimated $206K.
  • Cetera Advisor Networks first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 11 quarters.
  • Cetera Advisor Networks's Ionis Pharmaceuticals position peaked at $640K in Q2 2022.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.